Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma

Table 1

Response to neoadjuvant chemotherapy in 92 patients with NPC.

Response	Number of patients
	NP; ()	LN; ()	Combination; (NP + LN)
Responders
Complete response	24 (26.1%)	44 (55.0%)	20 (21.7%)
Partial response	55 (59.8%)	26 (32.5%)	56 (60.9%)
Nonresponders
Stable disease	13 (14.1%)	10 (12.5%)	16 (17.4%)
Progressive disease	0 (0%)	0 (0%)	0 (0%)

NP = nasopharynx; LN = regional neck lymph nodes.
12 patients with N0 disease were not included in the analysis.